Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Laboratorios Farmaceuticos Rovi, SA (ES:ROVI)
BME:ROVI
RESEARCH TOOLSreports
Laboratorios Farmaceuticos Rovi (ROVI) Stock Price & Analysis
7 Followers
ROVI Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€37.96 - €86.90
Previous Close€85.75
Volume13.49K
Average Volume (3M)79.28K
Market Cap
€4.57B
Enterprise Value€4.52B
Total Cash (Recent Filing)€124.94M
Total Debt (Recent Filing)€72.14M
Price to Earnings (P/E)26.1
Beta0.34
Next Earnings
Jul 24, 2024EPS EstimateN/A
Last Dividend Ex-Date
Jul 03, 2023Dividend Yield1.24%
Share Statistics
EPS (TTM)3.22
Shares Outstanding52,366,656
10 Day Avg. Volume55,135
30 Day Avg. Volume79,283
Standard Deviation0.09
R-Squared0.18
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€100.50Price Target Upside17.13% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Options Prices
Currently, No data available
---
Ownership Overview
60.38% Insiders
3.41% Mutual Funds
1.66% Other Institutional Investors
34.55% Public Companies and
Individual Investors
ROVI FAQ
What was Laboratorios Farmaceuticos Rovi, SA’s price range in the past 12 months?
Laboratorios Farmaceuticos Rovi, SA lowest stock price was €37.96 and its highest was €86.90 in the past 12 months.
What is Laboratorios Farmaceuticos Rovi, SA’s market cap?
Currently, no data Available
When is Laboratorios Farmaceuticos Rovi, SA’s upcoming earnings report date?
Laboratorios Farmaceuticos Rovi, SA’s upcoming earnings report date is Jul 24, 2024 which is in 68 days.
How were Laboratorios Farmaceuticos Rovi, SA’s earnings last quarter?
Currently, no data Available
Is Laboratorios Farmaceuticos Rovi, SA overvalued?
According to Wall Street analysts Laboratorios Farmaceuticos Rovi, SA’s price is currently Undervalued.
Does Laboratorios Farmaceuticos Rovi, SA pay dividends?
Laboratorios Farmaceuticos Rovi, SA pays a Annually dividend of €1.05 which represents an annual dividend yield of 1.24%. See more information on Laboratorios Farmaceuticos Rovi, SA dividends here
What is Laboratorios Farmaceuticos Rovi, SA’s EPS estimate?
Laboratorios Farmaceuticos Rovi, SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Laboratorios Farmaceuticos Rovi, SA have?
Laboratorios Farmaceuticos Rovi, SA has 54,016,155 shares outstanding.
What happened to Laboratorios Farmaceuticos Rovi, SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Laboratorios Farmaceuticos Rovi, SA?
Currently, no hedge funds are holding shares in ES:ROVI
---
Laboratorios Farmaceuticos Rovi Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€100.50 (17.13% Upside)
€100.50 (17.13% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
107.26%
12-Months-Change
Fundamentals
Return on Equity
32.16%
Trailing 12-Months
Asset Growth
-8.97%
Trailing 12-Months
Company Description
Laboratorios Farmaceuticos Rovi, SA
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments.
---
ROVI Stock 12 Month Forecast
Average Price Target
€100.50
▲(17.13% Upside)
Technical Analysis
Best Analysts Covering ROVI
1 Year
1 Year Success Rate
2/4 ratings generated profit
1 Year Average Return
+29.23%
assigned a buy rating 2 days ago
Copying James Vane's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +29.23% per trade.
---